Amylyx Pharmaceuticals, Inc. company logo
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$77.39M$92.81M-54.53%

Summary

Current Value
As of today, AMLX annual cash & cash equivalents is $77.39M, down -54.53% on
Historical Performance
AMLX annual cash & cash equivalents is up +54.19% over the past 3 years, and up +2424.99% over the past 5 years
All-Time High Comparison
AMLX annual cash & cash equivalents is currently -54.53% below its historical high of $170.20M set on
3-Year Low Comparison
AMLX annual cash & cash equivalents is +23.77% above its 3-year low of $62.53M reached on an earlier date
Sector Comparison
AMLX annual cash & cash equivalents is higher than 60.22% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AMLX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$77.39M-54.5%+54.2%+2425.0%+2425.0%
Quarterly Cash & Cash Equivalents$343.99M+46.8%+111.6%+100.0%+100.0%
Price$16.92+390.4%-54.1%
Annual Current Assets$189.43M-59.2%+80.5%+5816.1%+5816.1%
Annual Total Liabilities$28.87M-65.6%+65.6%+38.1%+38.1%
Annual Working Capital$161.03M-57.9%+91.4%+10000.0%+10000.0%
Annual Net Income-$301.74M-712.4%-243.2%-2099.9%-2099.9%

Cash and Cash Equivalents Highs

AMLX Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$170.20M-54.5%
5Y$170.20M-54.5%
All$170.20M-54.5%

Cash and Cash Equivalents Lows

AMLX Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$62.53MN/A+23.8%
5Y$12.88MN/A+501.0%
All$3.07M+2425.0%

Cash and Cash Equivalents History

YearValueChange
$77.39M-54.5%
$170.20M+172.2%
$62.53M+24.6%
YearValueChange
$50.19M+289.8%
$12.88M+320.1%
$3.07M-

FAQ

  • What is the current annual cash & cash equivalents of AMLX?

    As of today, AMLX annual cash & cash equivalents is $77.39M

  • What is 1-year change in AMLX annual cash & cash equivalents?

    AMLX annual cash & cash equivalents is down -54.53% year-over-year

  • What is 3-year change in AMLX annual cash & cash equivalents?

    AMLX annual cash & cash equivalents is up +54.19% over the past 3 years

  • How far is AMLX annual cash & cash equivalents from its all-time high?

    AMLX annual cash & cash equivalents is currently -54.53% below its historical high of $170.20M set on December 31, 2023

  • How does AMLX annual cash & cash equivalents rank versus sector peers?

    AMLX annual cash & cash equivalents is higher than 60.22% of companies in Healthcare sector

  • When is AMLX next annual earnings release?

    The next annual earnings release for AMLX is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. AMLX Official Website amylyx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1658551/000119312525268059/0001193125-25-268059-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658551/000095017025031309/0000950170-25-031309-index.htm
  4. AMLX Profile on Yahoo Finance finance.yahoo.com/quote/AMLX
  5. AMLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amlx